MedKoo Cat#: 534830 | Name: Murexine

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Murexine is a muscle relaxant.

Chemical Structure

Murexine
Murexine
CAS#20284-40-6

Theoretical Analysis

MedKoo Cat#: 534830

Name: Murexine

CAS#: 20284-40-6

Chemical Formula: C11H18N3O2+

Exact Mass: 224.1394

Molecular Weight: 224.28

Elemental Analysis: C, 58.91; H, 8.09; N, 18.74; O, 14.27

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Murexine
IUPAC/Chemical Name
Ethanaminium, 2-((3-(1H-imidazol-4-yl)-1-oxo-2-propenyl)oxy)-N,N,N-trimethyl-
InChi Key
XDPGNNXEHPAHCJ-UHFFFAOYSA-O
InChi Code
InChI=1S/C11H17N3O2/c1-14(2,3)6-7-16-11(15)5-4-10-8-12-9-13-10/h4-5,8-9H,6-7H2,1-3H3/p+1
SMILES Code
O=C(OCC[N+](C)(C)C)/C=C/C1=CNC=N1
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 224.28 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: ERSPAMER V, GLASSER A. The pharmacological actions of some murexine-like substances. Br J Pharmacol Chemother. 1958 Dec;13(4):378-84. doi: 10.1111/j.1476-5381.1958.tb00224.x. PMID: 13618539; PMCID: PMC1481884. 2: QUILLIAM JP. The mechanism of action of murexine on neuromuscular transmission in the frog. Br J Pharmacol Chemother. 1957 Sep;12(3):388-92. doi: 10.1111/j.1476-5381.1957.tb00153.x. PMID: 13460249; PMCID: PMC1509708. 3: Rudd D, Ronci M, Johnston MR, Guinan T, Voelcker NH, Benkendorff K. Mass spectrometry imaging reveals new biological roles for choline esters and Tyrian purple precursors in muricid molluscs. Sci Rep. 2015 Sep 1;5:13408. doi: 10.1038/srep13408. PMID: 26324173; PMCID: PMC4555103. 4: KEYL MJ, WHITTAKER VP. Some pharmacological properties of murexine (urocanoylcholine). Br J Pharmacol Chemother. 1958 Mar;13(1):103-6. doi: 10.1111/j.1476-5381.1958.tb00200.x. PMID: 13523145; PMCID: PMC1481681. 5: ERSPAMER V, GLASSER A. The pharmacological actions of murexine (urocanylcholine). Br J Pharmacol Chemother. 1957 Jun;12(2):176-84. doi: 10.1111/j.1476-5381.1957.tb00117.x. PMID: 13446370; PMCID: PMC1509659. 6: GRELIS ME, TABACHNICK II. The enzymatic hydrolysis of imidazoleacryloylcholine (murexine) and imidazolepropionylcholine (dihydromurexine) by various cholinesterases. Br J Pharmacol Chemother. 1957 Sep;12(3):320-2. doi: 10.1111/j.1476-5381.1957.tb00141.x. PMID: 13460237; PMCID: PMC1509698. 7: TABACHNICK II, ROTH FE, MERSHON J, RUBIN AA, ECKHARDT ET, GOVIER WM. Enzymic and pharmacologic comparison of imidazoleacetylcholine with two related choline esters, murexine and dihydromurexine. J Pharmacol Exp Ther. 1958 Jun;123(2):98-103. PMID: 13550062. 8: TABACHNICK II, ROTH FE. The potentiation of histamine by imidazoleacrylcholine (murexine) and imidazolepropionylcholine (dihydromurexine). J Pharmacol Exp Ther. 1957 Oct;121(2):191-8. PMID: 13481842. 9: CIOCATTO E, CATTANEO A, FAVA E. Esperienze cliniche con un nuovo curarizzante: murexina [Clinical experience with a new curarizing drug: murexine]. Minerva Anestesiol. 1956 Jun;22(6):197-202. Italian. PMID: 13348131. 10: ERSPAMER V, BENATI O. Identification of murexine as beta-(imidazolyl-(4))-acrylcholine. Science. 1953 Feb 13;117(3033):161-2. doi: 10.1126/science.117.3033.161. PMID: 13038472. 11: DE BLASI S, LEONE U. Uso clinico di un nuovo curarizzante: la murexina; nota preliminare [A new curare-simulant: murexine; preliminary report]. Minerva Anestesiol. 1955 Jun;21(6):137-41. Italian. PMID: 13244390. 12: ERSPAMER V, BENATI O. Isolierung des Murexins aus Hypobranchialdrüsenextrakten von Murex trunculus und seine Identifizierung als beta-[Imidazolyl-4(5)] acryl-cholin [Isolation of murexine from extracts of hypobranchial glands of Murex trunculus and its identification as beta-[imidazolyl-4(5)]-acryl-choline]. Biochem Z. 1953;324(1):66-73. Undetermined Language. PMID: 13093722. 13: FOLDES FF, ERDOS EG, BAART N, SHANOR SP. Interrelationship of murexine, dihydromurexine and human cholinesterases. Proc Soc Exp Biol Med. 1957 Mar;94(3):500-3. doi: 10.3181/00379727-94-22991. PMID: 13408305. 14: WINBURY MM. Muscarinic action of murexine and some related choline esters. Nature. 1957 Nov 9;180(4593):988-9. doi: 10.1038/180988a0. PMID: 13483576. 15: Valles-Regino R, Mouatt P, Rudd D, Yee LH, Benkendorff K. Extraction and Quantification of Bioactive Tyrian Purple Precursors: A Comparative and Validation Study from the Hypobranchial Gland of a Muricid Dicathais orbita. Molecules. 2016 Dec 5;21(12):1672. doi: 10.3390/molecules21121672. PMID: 27929402; PMCID: PMC6273837. 16: Ambache N, Zar MA. An inhibitory action of histamine on the guinea-pig ileum. Br J Pharmacol. 1970 Jan;38(1):229-40. doi: 10.1111/j.1476-5381.1970.tb10352.x. PMID: 4391734; PMCID: PMC1702650. 17: HOLMSTEDT B, WHITTAKER VP. Pharmacological properties of betabeta-di-methyl- acryloylcholine and some other beta-substituted acryloylcholines. Br J Pharmacol Chemother. 1958 Sep;13(3):308-14. doi: 10.1111/j.1476-5381.1958.tb00908.x. PMID: 13584734; PMCID: PMC1481777. 18: Roseghini M, Severini C, Erspamer GF, Erspamer V. Choline esters and biogenic amines in the hypobranchial gland of 55 molluscan species of the neogastropod Muricoidea superfamily. Toxicon. 1996 Jan;34(1):33-55. doi: 10.1016/0041-0101(95)00104-2. PMID: 8835333. 19: Erspamer V. Comparative histochemistry as a springboard for the discovery of biogenic amines and active peptides in molluscan tissues and amphibian skin. Basic Appl Histochem. 1981;25(1):3-14. PMID: 7259725. 20: Furutama D, Morita N, Takano R, Sekine Y, Sadakata T, Shinoda Y, Hayashi K, Mishima Y, Mikoshiba K, Hawkes R, Furuichi T. Expression of the IP3R1 promoter- driven nls-lacZ transgene in Purkinje cell parasagittal arrays of developing mouse cerebellum. J Neurosci Res. 2010 Oct;88(13):2810-25. doi: 10.1002/jnr.22451. PMID: 20632399.